Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

KZR

KZR News

Newswire

15:16

Kezar Life Sciences Downgraded to Hold from Buy with PT Cut to $7.

14:41

Kezar Life Sciences Begins Strategic Review After FDA Disagreement on Liver Drug Plans

10:37

Kezar Life Sciences: William Blair Downgrades to Market Perform from Outperform.

09:20

Wells Fargo Downgrades Kezar Life Sciences to Equal-Weight, PT to $5.

07:39

Kezar Life Sciences Shares Surge Amid FDA Break and Restructuring Plan

View More

About KZR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More